Target intelligence / Profile preview

Phosphatidylserine exposed on apoptotic cell membrane (PS)

Target
PS
Molecular classification
Phospholipid, Glycerophospholipid, "Eat me" signal molecule
01

Overview

Phosphatidylserine is a negatively charged phospholipid normally restricted to the inner leaflet of the plasma membrane in healthy cells[1][2][4]. During apoptosis, specific enzymes (scramblases such as Xkr8 and TMEM16F, and inactivation of flippases like ATP11A/ATP11C) cause PS to be translocated to the outer leaflet[3][4][5]. This surface-exposed phosphatidylserine acts as a crucial "eat me" signal, recognized by receptors on phagocytes, prompting the removal of dying cells[3][5][6]. PS exposure also provides a pro-coagulant surface for blood clotting factors on activated platelets[4], and is involved in immune system modulation and viral entry through apoptotic mimicry[1][2]. Therapeutically, exposed PS serves as a target for antibody therapies, imaging agents, and modulation of macrophage and dendritic cell function in cancer, inflammation, and viral infection[6]. Detection of exposed PS is a gold-standard marker for identifying apoptotic cells (e.g., through Annexin V staining)[6].

Other names
Phosphatidylserine (PS)Ptd-L-SerPtdSerExposed phosphatidylserineOuter-leaflet phosphatidylserine
02

Mechanism of action

Antibody-dependent cellular cytotoxicity following antibody binding to exposed PS. Blocking immunosuppressive signaling induced by PS exposure. Labeling for targeted imaging/therapeutics.

03

Biological functions

Apoptosis signalingCell removal (phagocytosis)Scaffold for blood clotting (platelet activation)Immune response modulationCell membrane structureViral entry via apoptotic mimicry
04

Disease associations

CancerInflammationInfectionCardiovascular disease (e.g., thrombosis)Neurodegenerative diseaseOther (autoimmune disorders through defective clearance)
05

Safety considerations

Off-target effects on normal apoptotic cell clearance, potentially causing autoimmunity or chronic inflammationEffects on coagulation (since exposed PS also scaffolds clotting)Immunogenicity of PS-targeted biologics
06

Interacting drugs

Bavituximab (an anti-phosphatidylserine antibody targeting exposed PS in solid tumors)

1 more in the full profile.

07

Biomarkers

Phosphatidylserine exposure detected by Annexin V staining for apoptotic cellsPS positivity as a marker for cell death rate in cancer and cardiovascular risk assessment

Beyond the preview

Go deeper on Phosphatidylserine exposed on apoptotic cell membrane (PS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylserine exposed on apoptotic cell membrane (PS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call